Publicaciones en colaboración con investigadores/as de Universidad de Granada (34)

2024

  1. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Scientific reports, Vol. 14, Núm. 1, pp. 3000

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. BCL7A is silenced by hypermethylation to promote acute myeloid leukemia

    Biomarker Research, Vol. 11, Núm. 1

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Opportunities of miRNAs in cancer therapeutics

    MicroRNA in Human Malignancies (Elsevier), pp. 153-164

  4. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer

    Cellular Oncology, Vol. 45, Núm. 2, pp. 323-332

2021

  1. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

    Journal of Clinical Investigation, Vol. 131, Núm. 23

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Pharmacological approaches for the modulation of the potassium channel kv4.X and KChIPs

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-21

2020

  1. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  2. Correction: Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer (Oncogene, (2020), 39, 32, (5479-5493), 10.1038/s41388-019-1129-3)

    Oncogene

  3. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

  4. LncRNA DLG2-AS1 as a novel biomarker in lung adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-10

  5. Lncrna-mrna co-expression analysis identifies al133346.1/ccn2 as biomarkers in pediatric b-cell acute lymphoblastic leukemia

    Cancers, Vol. 12, Núm. 12, pp. 1-15

  6. Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer

    Oncogene, Vol. 39, Núm. 32, pp. 5479-5493

2011

  1. Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice

    Brain Research Bulletin, Vol. 85, Núm. 3-4, pp. 133-140

2009

  1. Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in Parkinsonian mice

    Journal of Neuroscience Research, Vol. 87, Núm. 13, pp. 3002-3010

  2. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors

    European Journal of Medicinal Chemistry, Vol. 44, Núm. 6, pp. 2655-2666